Peter D. Staple is Director at DEPOMED INC (DEPO). They have made 14 open-market trades across 4 companies since 2009, most recently 2024-05-23.
CIK 0001271088
11 open-market purchases totalling $312K since 2009, against 3 sales. Across 11 scored buys the stock is up 13.5% at ninety days, and 11.8 points ahead of the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 100% | 100% |
| Avg Move | -19.5% | +10.3% | +13.5% |
| Alpha | -15.1% | +9.6% | +11.8% |
| Scored | 11 | 11 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ASRT | BUY | 2019-11-11 | 2019-11-12 | $0.71 | $10K | -3.0% | +61.8% | +78.9% |
| CORI | SELL | 2018-08-17 | 2018-08-17 | $8.96 | $308K | +9.3% | +3.0% | +41.4% |
| CORI | SELL | 2018-08-16 | 2018-08-17 | $8.66 | $341K | +9.3% | +3.0% | +41.4% |
| CORI | SELL | 2018-08-16 | 2018-08-17 | $8.81 | $1.3M | +9.3% | +3.0% | +41.4% |
| COR | BUY | 2016-05-13 | 2016-05-17 | $3.60 | $45K | -0.7% | +1.9% | +19.9% |
| CORI | BUY | 2015-02-25 | 2015-02-26 | $6.99 | $25K | -26.8% | +9.4% | +9.4% |
| CORI | BUY | 2014-11-21 | 2014-11-24 | $5.34 | $48K | -26.8% | +9.4% | +9.4% |
| CORI | BUY | 2014-08-25 | 2014-08-27 | $6.10 | $16K | -26.8% | +9.4% | +9.4% |
| CORI | BUY | 2014-05-28 | 2014-05-30 | $7.05 | $51K | -26.8% | +9.4% | +9.4% |
| DEPO | BUY | 2012-08-14 | 2012-08-15 | $5.01 | $25K | -20.6% | +2.4% | +2.4% |
| DEPO | BUY | 2011-09-09 | 2011-09-12 | $5.69 | $28K | -20.6% | +2.4% | +2.4% |
| DEPO | BUY | 2011-05-12 | 2011-05-13 | $8.14 | $41K | -20.6% | +2.4% | +2.4% |
| DEPO | BUY | 2009-06-15 | 2009-06-15 | $2.68 | $13K | -20.6% | +2.4% | +2.4% |
| DEPO | BUY | 2009-03-11 | 2009-03-12 | $2.00 | $10K | -20.6% | +2.4% | +2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.